Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia
Citation
AIHW
Australian Institute of Health and Welfare (2019) Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia, AIHW, Australian Government, accessed 24 April 2024.
APA
Australian Institute of Health and Welfare. (2019). Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia. Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia. AIHW, 2019.
Vancouver
Australian Institute of Health and Welfare. Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia. Canberra: AIHW; 2019.
Harvard
Australian Institute of Health and Welfare 2019, Analysis of cervical cancer and abnormality outcomes in an era of cervical screening and HPV vaccination in Australia, AIHW, Canberra.
PDF | 1.5Mb
This is the third report from an Australian-first project, combining screening, cancer, death, and HPV vaccination data to demonstrate the effects of screening and HPV vaccination on cervical cancer, precancerous abnormalities and cervical screening behaviour.
Screen-detected cervical cancers were less likely to cause death than those diagnosed in never-screened women, and HPV-vaccinated women were more likely to participate in cervical screening, and less likely to have a high-grade abnormality.
- ISSN: 2651-9623 (Online)
- ISBN: 978-1-76054-607-6 (Online)
- Cat. no: CAN 129
- Pages: 144
-
Participation in cervical screening was higher in HPV-vaccinated women than in unvaccinated women
-
Fewer high-grade cervical abnormalities occurred in HPV-vaccinated women than in unvaccinated women
-
Screen-detected cervical cancers were less likely to cause death than those in women who had never screened
-
Most cervical cancers (more than 70%) occurred in women who had never screened or who were lapsed screeners